CTRV - ContraVir Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/20176/30/20176/30/2016
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development7,593.71513,368.16513,651.98715,019.276
Selling General and Administrative7,000.4447,277.9517,371.8855,572.209
Non Recurring----
Others----
Total Operating Expenses14,594.15920,646.11621,023.87220,591.485
Operating Income or Loss-14,594.159-20,646.116-21,023.872-20,591.485
Income from Continuing Operations
Total Other Income/Expenses Net4,608.8645,618.5984,134.8193,592.847
Earnings Before Interest and Taxes-14,594.159-20,646.116-21,023.872-20,591.485
Interest Expense-339.158-339.158-339.158-339.158
Income Before Tax-9,985.295-15,027.518-16,799.053-16,998.638
Income Tax Expense-536-1,947.76-1,908.003-
Minority Interest----
Net Income From Continuing Ops-9,449.295-13,079.758-14,891.05-16,998.638
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-9,449.295-13,079.758-14,891.05-16,998.638
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-17,901.146-13,079.758-14,891.05-16,998.638